Northwestern Mutual Wealth Management
FULC icon

Northwestern Mutual Wealth Management’s Fulcrum Therapeutics FULC Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73K Hold
472
– – ﹤0.01% 3684
2026
Q1 		$3.62K Hold
472
– – ﹤0.01% 3415
2025
Q4 		$5.34K Buy
+472
New +$4.8K ﹤0.01% 3210

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northwestern Mutual Wealth Management's FULC Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Fulcrum Therapeutics (FULC) position steady in Q2 2026 at 472 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #3684.

Northwestern Mutual Wealth Management first reported a position in FULC in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.34K in Q4 2025. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Northwestern Mutual Wealth Management held 472 shares of Fulcrum Therapeutics worth $1.73K as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Fulcrum Therapeutics share count unchanged in Q2 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3684 holding.
  • Northwestern Mutual Wealth Management first reported a position in Fulcrum Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Northwestern Mutual Wealth Management's Fulcrum Therapeutics position peaked at $5.34K in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.